dysphonia
Conditions
Interventions
Experimental group: 13 women with behavioral dysphonia will receive 12 TENS sessions for 20 minutes followed by traditional vocal therapy for another 30 minutes. Low frequency TENS 10Hz, 200 microseco
Behavioural
Other
Sponsors
Faculdade de Odontologia de Bauru da Universidade de São Paulo
Faculdade de Odontologia de Bauru da Universidade de São Paulo
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: complaint of vocal alteration; altered voice evidenced by a speech-language auditory perceptual pre-assessment; bilateral vocal nodules or mucosal thickening or edema and glottic cleft on phonation; not having used TENS for any type of treatment
Exclusion criteria
Exclusion criteria: volunteers who had received speech therapy before; over 45 years of age; who reported being or had completed menstrual flow; who reported any general neurological alterations; thyroid gland changes, who had undergone clinical treatment for hormonal control (except contraceptive pill); vocal or surgical laryngeal treatment; heart problems, high blood pressure, hyper or hypothyroidism; smokers; alcoholics
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main outcome: Evaluate by vocal treatment with TENS followed by vocal therapy the vocal quality through perceptual analysis and vocal acoustics;Outcome 1: There was no change in vocal quality through perceptual analysis in both groups after treatment. There was a reduction in the acoustic parameter SPI (mild phonation index) for both groups after 12 treatment sessions and one month after).;Outcome 2: Decreased nodular vocal fold lesion size only for EG immediately after one month of treatment;Outcome found 3: There was no change in voice-related quality of life for both groups. There was improvement in vocal self-perception for both groups immediately and after one month of treatment.;Outcome 4: Reduction of musculoskeletal pain in the proximal regions of the larynx in both groups. The EG showed an increase in the trapezius muscle pain threshold;Expected Outcome 2: To evaluate vocal treatment with TENS followed by vocal therapy for laryngeal aspects by nasolaryngoscopy.;Expected outcomes 3: Evaluate vocal treatment with TENS followed by vocal therapy for voice-related quality of life using the QoL protocol;Expected Outcome 4: To evaluate vocal treatment with TENS followed by vocal therapy for musculoskeletal pain through the Musculoskeletal Pain Investigation protocol, and trapezius muscle pain threshold using the digital algometer;Expected Outcome 5: Muscle activity by surface electromyography of the trapezius, sternocleidomastoid, infra and suprahyoid muscles It has not been analyzed to date | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcomes. | — |
Countries
Brazil
Contacts
Public ContactKelly Silverio
Faculdade de Odontologia de Bauru
Outcome results
None listed